Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs Freeport-McMoRan Inc (FCX) Price & Performance

Centene CorpTrade
Freeport-McMoRan IncTrade

Price performance (Past 24H)

Key statistics

Centene Corp vs Freeport-McMoRan Inc — how do they compare? Centene Corp trades at $66.47 (market cap $33.93B), while Freeport-McMoRan Inc trades at $61.02 (market cap $89.06B). The key difference: Freeport-McMoRan Inc is far larger — about 2.6× Centene Corp's market cap, and Freeport-McMoRan Inc pays a 0.97% dividend while Centene Corp pays none. Which is the better fit depends on your goals.

CNCFCX
Market Cap
$33.93B$89.06B
Sector
HealthBasic Materials
52-Week High
$68.72$71.73
52-Week Low
$25.21$35.34
Enterprise Value
$26.56B$95.72B
Dividend Yield
0.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

Freeport-McMoRan Inc

FCX trades at $59.98, down 2.51% today, with a bearish technical signal but strong fundamentals. Recent earnings beats and a 10.34% net income margin highlight operational strength. The stock faces near-term resistance at $61, with support at $59. Analysts maintain a $72.94 consensus target, reflecting 22% upside potential. Copper demand growth and expansion projects support long-term prospects.

Outlook remains positive driven by copper's structural supply-demand imbalance and FCX's cost leadership. Risks include commodity price volatility and execution challenges in new projects. Institutional sentiment is bullish with 59% buy ratings, though technical indicators suggest near-term consolidation. The dividend yield of 0.25% provides modest income support.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About Freeport-McMoRan Inc

Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia

Read more on FCX